Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image

Drugs Linked With Cyclist’s Death

(N.Z.P.A.-Reuter— Copyright)

AVIGNON (Southern France).

Dangerous drugs could have been a contributory factor in the death of the British racing cyclist, T. Simpson, in the Tour de France last month, an official medical report concluded.

The report, released by the Avignon public prosecutor, said that Simpson, aged 29, had died of heart failure due to exhaustion. "The unfavourable atmospheric conditions, intense over-exertion and the use of dangerous medicines could have contributed to the exhaustion syndrome,” the report said. The report said traces of chemical substances found in Simpson's body would not alone have been enough to kill him, but might have led him to go beyond the limit of his strength. Simpson slumped unconscious from his machine as he was nearing the summit of the 6000 ft Mount Ventoux in a sweltering 904egree heatwave. He was taken by helicopter

to hospital but died shortly afterwards. His death was the first in the 54-year history of the Tour de France.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/CHP19670807.2.130

Bibliographic details

Press, Volume CVII, Issue 31441, 7 August 1967, Page 11

Word Count
164

Drugs Linked With Cyclist’s Death Press, Volume CVII, Issue 31441, 7 August 1967, Page 11

Drugs Linked With Cyclist’s Death Press, Volume CVII, Issue 31441, 7 August 1967, Page 11

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert